RECENT ARTICLES
Wagner’s Prigozhin Planned to Capture Russian Military Leaders
Mercenary leader Yevgeny Prigozhin planned to capture Russia’s military leadership as part of last weekend’s mutiny, Western officials said, and he accelerated his plans after the country’s domestic intelligence agency became aware of the plot.…Mercenary leader Yevgeny Prigozhin planned to capture Russia’s military leadership as part of last weekend’s mutiny, Western officials said, and he accelerated his plans after the country’s domestic intelligence agency became aware of the plot.WW…
Elon Musk’s Satellite Internet Project Is Too Risky, Rivals Say
Skip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.https://www.wsj.com/articles/elon-musks-satellite-internet-project-is-too-risky-rivals-say-11618827368ShareBy April 19, 2021 6:16 am ETListen to article(2 minutes)’s internet satellite venture has spawned an unlikely alliance of competitors, regulators and experts who say the billionaire is...…Skip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.https://www.wsj.com/articles/elon-musks-satellite-internet-project-is-too-risky-rivals-say-11618827368ShareBy April 19, 2021 6:16 am ETListen to article(2 minutes)’s internet satellite venture has spawned an unlikely alliance of competitors, regulators and experts who say the billionaire is...WW…
More Than 25% of U.S. Has Received a Covid-19 Vaccine Dose
Skip to Main ContentSkip to Search…Skip to Main ContentSkip to SearchWW…
Some Covid-19 Vaccines Are Effective After One Dose, Can Be Stored in Normal Freezers, Data Show
ByandEfforts to vaccinate the world’s population against Covid-19 got a boost Friday after research showed that some vaccines provide strong, one-dose protection, and that one of the vaccines can now be stored in normal freezers instead of ultra-cold ones. The vaccine developed by Pfizer Inc. and BioNTech SE generates robust immunity after one dose, according to new research out of Israel, and further data showed that the University of Oxford and AstraZeneca PLC vaccine similarly prevented Covid-19 when doses were spaced three...Efforts to vaccinate the world’s population against Covid-19...…ByandEfforts to vaccinate the world’s population against Covid-19 got a boost Friday after research showed that some vaccines provide strong, one-dose protection, and that one of the vaccines can now be stored in normal freezers instead of ultra-cold ones. The vaccine developed by Pfizer Inc. and BioNTech SE generates robust immunity after one dose, according to new research out of Israel, and further data showed that the University of Oxford and AstraZeneca PLC vaccine similarly prevented Covid-19 when doses were spaced three...Efforts to vaccinate the world’s population against Covid-19...WW…
WSJ News Exclusive | German Biotech Sees Its Coronavirus Vaccine Ready for Approval by December
Skip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.https://www.wsj.com/articles/german-biotech-sees-its-coronavirus-vaccine-ready-for-approval-by-december-11594373400ShareBy July 10, 2020 5:30 am ETBERLIN—The German biotech firm that has partnered with Pfizer Inc. to develop a coronavirus vaccine is confident it will be ready to seek...…Skip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.https://www.wsj.com/articles/german-biotech-sees-its-coronavirus-vaccine-ready-for-approval-by-december-11594373400ShareBy July 10, 2020 5:30 am ETBERLIN—The German biotech firm that has partnered with Pfizer Inc. to develop a coronavirus vaccine is confident it will be ready to seek...WW…
- Total 5 items
- 1